Top Markets
Coin of the day
Acusphere, Inc. Acusphere, Inc.

Acusphere, Inc.

ACUS
Rank in Stocks #42813
Acusphere, Inc. is a pharmaceutical firm specializing in the creation and... Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease. This drug is administered as an injectable suspension. Initially established as Polymers For Medicine, Inc., the organization rebranded as Acusphere, Inc. in March 2004. Founded in 1993, the company maintains its headquarters in Watertown, Massachusetts.
Share Price
$0.00001
Last synced: 2026-08-11
Market Cap
$49.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Acusphere, Inc. (ACUS)

Category

Revenue for Acusphere, Inc. (ACUS)
Revenue in Aug 2026 TTM: 0
According to Acusphere, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Acusphere, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors